Important Disclaimer. This guide is for educational purposes only. Peptide research compounds are not approved by the HPRA or EMA for human use in Ireland or the EU. This article describes reconstitution procedures as documented in scientific and research literature. Nothing here constitutes medical advice or guidance on self-administration. Always operate within applicable legal and ethical frameworks. Consult a qualified healthcare professional for any health decisions.

What Is Reconstitution and Why Does It Matter?

Peptides are supplied as lyophilised (freeze-dried) powder in sealed glass vials. Lyophilisation removes virtually all moisture from the compound, which dramatically extends shelf life and maintains stability at room temperature during shipping. However, the powder cannot be used in this dry form — it must first be dissolved in a liquid diluent to create a solution.

This process is called reconstitution. Getting it right is critical for two reasons:

  1. Accuracy: The concentration you achieve determines every subsequent dose calculation. An error in reconstitution propagates through every use of that vial.
  2. Sterility and stability: Peptide solutions are biologically active and can degrade or become contaminated if handled incorrectly. Proper reconstitution technique preserves the integrity of the compound for the duration of its use.

This guide covers the complete reconstitution process from start to finish, including why specific materials are used, how to perform the calculations, and how to store the reconstituted solution correctly.

Bacteriostatic Water vs. Sterile Water: Why It Matters

The most common question beginners ask is: can I use regular sterile water for injection (WFI — water for injection) instead of bacteriostatic water? The answer depends on how the vial will be used.

Sterile Water for Injection (WFI)

Sterile water is exactly what it sounds like — ultra-pure water that has been sterilised and is pyrogen-free. It is the appropriate diluent for single-use vials only. Once a vial of sterile water is opened and a needle is inserted, the sterility of the remaining contents cannot be guaranteed. Any residual solution should be discarded after a single use.

Bacteriostatic Water (BW)

Bacteriostatic water contains 0.9% benzyl alcohol (9 mg/ml) as a preservative. Benzyl alcohol inhibits the growth of most common bacteria, making the solution safe for use across multiple draws from the same vial. This is the standard choice for any peptide vial that will be accessed more than once — which, given the cost and typical multi-dose nature of research peptide vials, is essentially always.

Key properties of bacteriostatic water to understand:

  • The benzyl alcohol preservative does not meaningfully alter peptide stability for the vast majority of compounds
  • Once a vial of bacteriostatic water is opened (i.e., a needle has been inserted), it should be used within 28 days and discarded thereafter
  • Bacteriostatic water is a pharmaceutical-grade product and should be sourced accordingly — not improvised from tap water or homemade preparations
  • It is widely available from pharmacy suppliers and laboratory supply companies in Ireland and the EU

Equipment You Will Need

Before beginning reconstitution, gather all required equipment. Working in a clean environment with all materials to hand reduces the risk of contamination and procedural error.

Lyophilised peptide vial
Your research compound — store in a cool, dry place before reconstitution
Bacteriostatic water
Pharmaceutical grade, 0.9% benzyl alcohol — typically in 30ml multi-dose vials
U-100 insulin syringes
1ml capacity with 28–31 gauge needle; used both to transfer BW and to draw doses
Alcohol wipes (70% isopropyl)
To sterilise rubber stoppers before every needle insertion
Clean work surface
Wipe down with isopropyl alcohol before starting; avoid areas with air currents
Sharps disposal container
Required for safe disposal of used needles; available from pharmacies in Ireland

Step-by-Step Reconstitution Protocol

  1. Prepare your workspace. Wipe down your work surface with an isopropyl alcohol wipe. Wash your hands thoroughly. Lay out all equipment within easy reach. Avoid working in areas with drafts or air conditioning blowing directly across your workspace.
  2. Inspect the peptide vial. Examine the lyophilised powder. It should appear as a white or off-white powder or cake, dry and intact. Do not use a vial where the powder appears wet, discoloured, or degraded, or where the vacuum seal appears to have been broken.
  3. Sterilise both stoppers. Use a fresh alcohol wipe to clean the rubber stopper on the peptide vial. Use a second wipe (or the other end of the same wipe) to clean the stopper on your bacteriostatic water vial. Allow both to air-dry for 15–20 seconds — do not blow on them or wave them dry.
  4. Draw the bacteriostatic water. Insert your insulin syringe needle through the rubber stopper of the bacteriostatic water vial. Draw back the plunger to pull in the required volume of BW. The volume depends on your desired final concentration — see the calculation section below. Remove the syringe from the BW vial.
  5. Insert into the peptide vial at an angle. Insert the needle through the rubber stopper of the peptide vial, angling the needle so that the tip rests against the inside wall of the glass. This is important — you do not want the liquid to jet directly onto the lyophilised powder.
  6. Release the water slowly down the vial wall. Depress the plunger slowly and steadily, allowing the bacteriostatic water to run gently down the inside wall of the vial and onto the powder. Take 10–15 seconds for this step. The slower the better — turbulence from rapid injection can shear and degrade sensitive peptides.
  7. Do not shake — swirl gently. Remove the syringe and hold the vial between your fingers, rolling it gently in a circular motion. Most peptides dissolve within 1–3 minutes of swirling. Some (notably CJC-1295 and certain growth hormone secretagogues) may take 10–30 minutes to fully dissolve. Patience here is important. If you have swirled for 5 minutes and see undissolved material, place the vial in the refrigerator and return in 30 minutes.
  8. Inspect the solution. The reconstituted solution should be clear and colourless (some peptides produce a very slightly yellowish tint, which is acceptable). It should contain no visible particles, cloudiness, or precipitation. If the solution is cloudy or particulate, do not use it — the peptide may have degraded or been contaminated.
  9. Label and refrigerate immediately. Write the date of reconstitution on the vial label. Refrigerate at 2–8°C. The reconstituted peptide is now ready for use within the shelf life window (see storage section below).

Concentration Calculations

Getting the concentration right determines how much volume you draw for each dose. The maths is straightforward, but precision matters — especially when working with compounds measured in micrograms.

The Basic Formula

Concentration (mcg/ml) = Vial size (mg) × 1000 ÷ Volume of BW added (ml)

Worked Example: 5mg BPC-157 vial

Vial: 5mg BPC-157

Bacteriostatic water added: 2ml

Concentration = 5 × 1000 ÷ 2 = 2,500 mcg/ml

To draw 250mcg: 250 ÷ 2500 = 0.1ml = 10 IU on a U-100 syringe

To draw 500mcg: 500 ÷ 2500 = 0.2ml = 20 IU on a U-100 syringe

On a U-100 insulin syringe, 1 IU = 0.01ml. So a 100 IU syringe holds exactly 1ml total. This means:

  • 10 IU = 0.10ml
  • 20 IU = 0.20ml
  • 50 IU = 0.50ml

The most common reconstitution approach is to add enough bacteriostatic water to create a concentration where the dose you are using equals a round number of IU on your syringe — this minimises measurement error. Use our Peptide Reconstitution Calculator to run these calculations automatically for any vial size, water volume, and dose combination.

Why the Amount of Water You Add Matters

Many beginners assume more water is always better (easier to measure small volumes). In practice, adding too much water to a small vial creates very dilute solutions where each dose requires a large volume — potentially close to, or exceeding, the total volume you can practically inject subcutaneously at one site (typically limited to about 0.5–1ml maximum). Too little water creates an overly concentrated solution where tiny measurement errors translate to large dose differences. A concentration that puts your typical dose at 10–30 IU on a U-100 syringe is usually the sweet spot.

Storage: Temperature, Shelf Life, and Stability

Peptides are proteins, and proteins are sensitive to temperature, light, and repeated freeze-thaw cycles. Correct storage is not optional — it directly affects whether the compound retains its biological activity.

Lyophilised Powder (Before Reconstitution)

  • Short-term storage (up to 3 months): Refrigerate at 2–8°C, away from light
  • Long-term storage (months to years): Freeze at −20°C in a consistent-temperature freezer (not a frost-free freezer, which cycles temperatures). Most lyophilised peptides are stable for 1–2 years under these conditions.
  • Transport: Dry lyophilised peptides are relatively tolerant of short-term temperature fluctuations during shipping, but should be moved to cold storage promptly upon arrival

Reconstituted Solution

  • Refrigerate at 2–8°C immediately after reconstitution
  • Use within 4 weeks (28–30 days) of reconstitution for most peptides when stored correctly with bacteriostatic water
  • Do not freeze reconstituted peptide solutions. Ice crystal formation during freezing can disrupt the peptide's three-dimensional structure and cause partial degradation. If you need to store a reconstituted solution beyond 4 weeks, the appropriate approach is to not reconstitute it in the first place — keep it lyophilised until needed.
  • Protect from light. Store in the original vial (which is typically amber-coloured or opaque) in the refrigerator. Do not leave the vial on a brightly lit bench for extended periods.
  • Discard if: the solution becomes cloudy, develops a yellow or brown discolouration, contains visible particles, or smells unusual. All of these are signs of degradation or contamination.

Common Mistakes to Avoid

Shaking the vial. Vigorous shaking creates foam and can mechanically degrade peptide bonds. Always swirl gently, never shake.
Injecting BW directly onto the powder. This can cause localised overconcentration and clumping. Always angle the needle so BW runs down the vial wall.
Skipping stopper sterilisation. Every needle insertion is a contamination risk. Wipe with isopropyl alcohol every single time, without exception.
Using tap water or saline instead of bacteriostatic water. Tap water is not sterile. Normal saline (0.9% NaCl) lacks a preservative and is for single-use only. Neither is appropriate for multi-dose peptide vials.
Freezing reconstituted solution. Ice crystal formation disrupts peptide structure. Keep reconstituted solutions refrigerated at 2–8°C, not frozen.
Miscalculating concentration. Always double-check your maths before drawing the first dose. A factor-of-10 error here means every subsequent measurement is wrong. Use the Peptide Calculator to verify.
Not labelling the vial with the reconstitution date. Reconstituted peptides have a 28–30 day window. Without a date on the vial, you cannot track this. Label immediately after reconstitution.

Irish and EU Regulatory Context

For the avoidance of doubt: peptide research compounds including BPC-157, TB-500, CJC-1295, Ipamorelin, and others are not approved for human use by the HPRA (Health Products Regulatory Authority) in Ireland or the EMA (European Medicines Agency) at the EU level.

These compounds exist in a regulatory grey area in Ireland. They are not scheduled controlled drugs under the Misuse of Drugs Acts, but they are also not licensed medicinal products. Supplying them with health claims or for therapeutic human use constitutes supply of an unlicensed medicinal product, which is an offence under Irish medicines legislation.

The reconstitution knowledge in this guide is documented in academic and scientific literature. It is relevant to licensed researchers working within approved institutional frameworks. Anyone conducting research involving these compounds in Ireland should ensure they have appropriate institutional ethics approval and regulatory clearance in place before proceeding.

Reminder. This guide is for educational purposes only. Peptide compounds are not approved for human use in Ireland or the EU. This article does not constitute medical advice. Always operate within the applicable legal framework and consult a qualified healthcare professional for any health-related decisions.

Skip the maths — use our free calculator

Enter your vial size and the volume of bacteriostatic water you plan to add. Our Peptide Calculator instantly outputs concentration, dose volumes, and a full reference table for common doses.

Open Peptide Calculator